Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.27B |
| 2 |
Microsoft
MSFT
|
+$490M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 4 |
Johnson & Johnson
JNJ
|
+$337M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$317M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$773M |
| 2 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$727M |
| 3 |
Palo Alto Networks
PANW
|
+$543M |
| 4 |
Colgate-Palmolive
CL
|
+$540M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$348M |
Sector Composition
| 1 | Technology | 23.7% |
| 2 | Financials | 13.93% |
| 3 | Healthcare | 12.61% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Communication Services | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFIV
1176
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $4.18M | ﹤0.01% |
420,235
+281,021
| +202% | +$2.8M |
|
1177
Crocs
CROX
$4.44B
| $4.18M | ﹤0.01% |
60,855
+32,441
| +114% | +$2.23M |
|
1178
The Ensign Group
ENSG
$9.76B
| $4.18M | ﹤0.01% |
52,530
+13,731
| +35% | +$1.09M |
|
1179
CubeSmart
CUBE
$9.44B
| $4.17M | ﹤0.01% |
104,116
+20,049
| +24% | +$803K |
|
1180
Dynavax Technologies
DVAX
$1.13B
| $4.15M | ﹤0.01% |
397,501
+359,235
| +939% | +$3.75M |
|
|
SAGE
1181
DELISTED
Sage Therapeutics
SAGE
| $4.13M | ﹤0.01% |
105,566
+99,159
| +1,548% | +$3.88M |
|
1182
Prothena Corp
PRTA
$448M
| $4.13M | ﹤0.01% |
68,062
+66,281
| +3,722% | +$4.02M |
|
1183
TD Synnex
SNX
$12.6B
| $4.1M | ﹤0.01% |
50,554
+44,189
| +694% | +$3.59M |
|
1184
Jamf
JAMF
$1.37B
| $4.1M | ﹤0.01% |
185,134
+6,599
| +4% | +$146K |
|
1185
Medpace
MEDP
$13.8B
| $4.1M | ﹤0.01% |
26,092
+14,963
| +134% | +$2.35M |
|
|
LADR
1186
Ladder Capital
LADR
$1.51B
| $4.1M | ﹤0.01% |
457,429
+86,341
| +23% | +$774K |
|
1187
UFP Industries
UFPI
$6B
| $4.1M | ﹤0.01% |
56,742
+10,122
| +22% | +$731K |
|
|
JJT
1188
DELISTED
iPath Series B Bloomberg Tin Subindex Total ReturnSM ETN
JJT
| $4.07M | ﹤0.01% |
64,000
| – | – |
|
1189
Celldex Therapeutics
CLDX
$1.66B
| $4.06M | ﹤0.01% |
144,587
+47,500
| +49% | +$1.34M |
|
1190
WEX
WEX
$6.02B
| $4.06M | ﹤0.01% |
31,986
+16,484
| +106% | +$2.09M |
|
1191
Cable One
CABO
$973M
| $4.04M | ﹤0.01% |
4,741
+1,163
| +33% | +$992K |
|
1192
Axon Enterprise
AXON
$58.9B
| $4.04M | ﹤0.01% |
34,872
-9,319
| -21% | -$1.08M |
|
1193
Rhythm Pharmaceuticals
RYTM
$6.51B
| $4.03M | ﹤0.01% |
164,353
+155,063
| +1,669% | +$3.8M |
|
|
ZPTA
1194
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
| $4.02M | ﹤0.01% |
400,000
| – | – |
|
|
AVID
1195
DELISTED
Avid Technology Inc
AVID
| $4.02M | ﹤0.01% |
172,961
+171,165
| +9,530% | +$3.98M |
|
1196
Ovintiv
OVV
$10.8B
| $4.02M | ﹤0.01% |
87,422
-67,036
| -43% | -$3.08M |
|
|
JWAC
1197
DELISTED
Jupiter Wellness Acquisition Corp. Class A Common Stock
JWAC
| $4.02M | ﹤0.01% |
400,302
+302
| +0.1% | +$3.03K |
|
1198
Fox Class B
FOX
$25.8B
| $4.01M | ﹤0.01% |
140,838
+58,431
| +71% | +$1.67M |
|
1199
Fate Therapeutics
FATE
$119M
| $4.01M | ﹤0.01% |
178,915
+158,098
| +759% | +$3.54M |
|
1200
MSC Industrial Direct
MSM
$5.12B
| $4.01M | ﹤0.01% |
55,040
+43,992
| +398% | +$3.2M |
|